Adrien Metivet

A French & European Patent Attorney, Adrien Metivet specialises in chemistry, pharmaceuticals, cosmetics, in particular, organic, organometallic, inorganic, mineral and organomineral chemistry, polymer chemistry, polysaccharide chemistry, catalysts, electrochemistry, organosynthesis, asymmetric synthesis, multi-stage synthesis of bioactive molecules, chromatography and spectroscopic techniques (NMR, MS, LC-MS).

He develops IP strategies to protect inventions, drafts supplementary protection certificates and advises on the validity of third-party patents.

Career history

Adrien holds a Doctorate in Chemistry (University of Strasbourg), a Master's degree in Molecular and Supramolecular Chemistry (Université Louis Pasteur, Strasbourg) and a degree in Chemical Engineering (Ecole Européenne de Chimie, Polymères et Matériaux, Strasbourg). He also holds a degree from the Centre for International Intellectual Property Studies (CEIPI), majoring in patents (University of Strasbourg) in 2014. Adrien has been a French Patent Attorney since 2015 and a European Patent Attorney at the EPO since 2016.

Adrien began his career at a company in Lyon in 2011 and joined the Novagraaf Technologies team in 2017.

Memberships

Adrien is a member of the European Patent Institute (EPI) and the professional association of French patent and trademark attorneys (CNCPI).

Languages

• English
• French

Areas of expertise

• Patents and supplementary protection certificates
• Expert reports on freedom to operate, patentability, infringement and validity of patents.
• Drafting of patents (French and English) and management of procedures for the granting of French, European, international (PCT) and foreign patent applications (in particular the main target countries: USA, Canada, Japan, South Korea, China, India, Australia).
• Optimised and strategic management of patent portfolios.
• Examination, opposition and appeal procedures before the European Patent Office.
• Litigation and pre-litigation cases, including the marketing of generic drugs or products, risk assessment, strategic advice in attack and defence, and litigation monitoring.
• Protection of inventions in the field of pharmaceuticals (for human or veterinary use), supplementary protection certificates and protection strategies.
• Validity studies of third-party patents – presentation of risks and preparation of pre-litigation files.